Zai Lab Ltd ADR (ZLAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 788,806 | 859,155 | 879,844 | 1,008,470 | 1,119,476 |
| Marketable Securities | 31,600 | 15,500 | 50,550 | N/A | N/A |
| Receivables | 41,596 | 47,283 | 43,346 | 39,963 | 28,816 |
| Inventories | 44,229 | 36,353 | 38,405 | 31,621 | 29,131 |
| Other current assets | 23,679 | 20,781 | 17,381 | 8,608 | 10,251 |
| TOTAL | $959,731 | $1,017,505 | $1,072,298 | $1,124,336 | $1,209,831 |
| Non-Current Assets | |||||
| PPE Net | 55,282 | 56,410 | 58,309 | 57,863 | 50,528 |
| Investments And Advances | 4,466 | 5,128 | 6,872 | 6,431 | 3,316 |
| Intangibles | 4,625 | 4,757 | 8,399 | 8,403 | 8,364 |
| Other Non-Current Assets | 19,590 | 22,573 | 24,196 | 23,107 | 26,475 |
| TOTAL | $83,963 | $88,868 | $97,776 | $95,804 | $88,683 |
| Total Assets | $1,043,694 | $1,106,373 | $1,170,074 | $1,220,140 | $1,298,514 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 55,020 | 67,031 | 66,361 | 65,974 | 90,112 |
| Other current liabilities | 62,990 | 59,024 | 50,881 | 66,818 | 58,456 |
| TOTAL | $124,896 | $133,354 | $124,560 | $139,842 | $155,548 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10,133 | 12,080 | 13,304 | 13,343 | 13,892 |
| TOTAL | $37,819 | $40,705 | $44,272 | $34,703 | $37,097 |
| Total Liabilities | $162,715 | $174,059 | $168,832 | $174,545 | $192,645 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,839 | 98,389 | 97,909 | 97,909 | 97,909 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -2,100,551 | -2,031,399 | -1,910,504 | -1,861,360 | -1,799,591 |
| Other shareholders' equity | 48,162 | 52,654 | 17,286 | 25,829 | 39,093 |
| TOTAL | $880,979 | $932,314 | $1,001,242 | $1,045,595 | $1,105,869 |
| Total Liabilities And Equity | $1,043,694 | $1,106,373 | $1,170,074 | $1,220,140 | $1,298,514 |